An experimental drug helped people with Type 2 diabetes lose more than one-fifth of their body weight in a clinical trial.

With next-generation metabolic combinations continuing to set new standards in the clinic, type 2 diabetes and chronic weight ...

People with obesity or overweight and type 2 diabetes lost up to 13.1% of their body weight with survodutide over 76 weeks.

The Danish global pharmaceutical company Novo Nordisk claimed that its late stage trial had met its main goal of reducing glucose (BG) levels in a trial involving about 1,200 patients over a ...

Adults with type 2 diabetes will have a new alternative to daily insulin injections now that the U.S. Food and Drug Administration (FDA) approved a new once-a-week insulin injection.

The European Association for the Study of Diabetes and the American Diabetes Association have updated their joint guidance on T2D management.

Share on Pinterest Scientists are working on alternatives to drugs like Ozempic to treat diabetes and obesity. Westend61/Getty Images A new study published by Swedish researchers shared results of the ...

Share on Pinterest AstraZeneca’s new oral GLP-1 pill showed promising results for weight loss and blood sugar in a phase 2 trial. Guido Mieth/Getty Images A new GLP-1 oral medication from AstraZeneca, ...